Title | Use of neutrophil gelatinase-associated lipocalin in manufacture of medicament for prevention or treatment of polycystic kidney disease |
Year | 2024 |
Country | CA |
Inventor | HSIEH, HSIU-MEI |
Co-inventor | WANG, YI-REN ; JIANG, SI-TSE; JENG, WEN-YIH; CHIOU, YUAN-YOW |
Cert. No. | CA 2952487 |
Introduction | Disclosed is the use of neutrophil gelatinase-associated lipocalin (NGAL) in the manufacture of a medicament for prevention and treatment of polycystic kidney diseases. By administration of NGAL, the lifespan of patients can be prolonged. |
Validity | 2036/12/19 |
Domain | Medicine and Health |
View count:
107